PT - JOURNAL ARTICLE AU - Campos-Pardos, Elena AU - Calvet-Seral, Juan AU - Aguilera, Antonio AU - Milagro-Beamonte, Ana AU - Martínez-Sapiña, Ana AU - Barbeito, Gema AU - del Molino, María Luisa Pérez AU - Gonzalo-Asensio, Jesús TI - Discrepancies in the detection of SARS-CoV-2 by qRT-PCR are dependent on the target gene used for its amplification: Implications in the diagnosis of clinical infection AID - 10.1101/2021.08.30.21262536 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.30.21262536 4099 - http://medrxiv.org/content/early/2021/08/31/2021.08.30.21262536.short 4100 - http://medrxiv.org/content/early/2021/08/31/2021.08.30.21262536.full AB - Discrepancies exist in Cycle threshold (Ct) values during detection of SARS-CoV-2 by qRT-PCR. We demonstrate that Ct values depend on the position of the target gene in the viral genome. Simultaneous detection of five genes in positive samples revealed lower Ct values as we move further to the 3’ end (orf1AB/RdRp>E>M>orf7a>N). These findings were confirmed in a retrospective analysis with 363 positive clinical samples. Our findings have key implications in clinical diagnostics of SARS-CoV-2, patient management and public health interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from Oficina de Transferencia de Resultados de Investigacion-University of Zaragoza (reference Valle de la Muerte 2020) and by Santander-UNIZAR COVID-19 call to J. G.-A. E. C.-P. is beneficiary from a FPU grant (reference FPU17/02909) from the Spanish Ministry of Education, Culture and Sport. J. C.-S. is beneficiary from a DGA grant from Gobierno de Aragon.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was evaluated by the Ethics Committee for Research in the Autonomous Community of Aragon (Comite de Etica para la Investigacion en la Comunidad Autonoma de Aragon)-CEICA (Reference SA21-12), and the ethics approval was favorable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the published data will be available upon request